Literature DB >> 7227420

In vivo tumor response to single and multiple exposures of adriamycin.

D W Siemann, R M Sutherland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7227420     DOI： 10.1016/0014-2964(80)90052-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  The in situ tumour response to combinations of cyclophosphamide and tirapazamine.

Authors:  D W Siemann
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

3.  Chemopotentiation in vivo: no loss of sensitization with fractionation.

Authors:  S A Hill; D W Siemann
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

4.  Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

5.  Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation.

Authors:  D W Siemann; E M Lord; P C Keng; K T Wheeler
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

6.  In vivo tumour-cell proliferation after adriamycin treatment.

Authors:  R Rowley; H A Hopkins; W B Looney
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.